Kolinsky Wealth Management, LLC Durect Corp Transaction History

Kolinsky Wealth Management, LLC

  • $162 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.38 - $0.64 $380 - $640
1,000 Added 7.14%
15,000 $7,000
Q1 2022

May 12, 2022
BUY
$0.55 - $0.98 $7,700 - $13,720
14,000 New
14,000 $9,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
599K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $196M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Kolinsky Wealth Management, LLC Portfolio

Follow Kolinsky Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kolinsky Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kolinsky Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email